286 results on '"Sastry, K. Jagannadha"'
Search Results
2. Efficacy of oleandrin and PBI-05204 against viruses of importance to commercial pig health management
3. A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice
4. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2
5. Mucoadhesive wafers composed of binary polymer blends for sublingual delivery and preservation of protein vaccines
6. Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications
7. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation
8. Immunity from NK Cell Subsets Is Important for Vaccine-Mediated Protection in HPV+ Cancers.
9. Supplemental Tables from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers
10. Data from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers
11. Supplemental Table Legends from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers
12. Supplementary Data from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers
13. Table S3 from Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice
14. Data from Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice
15. Supplementary Figure Legends from Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice
16. Supplementary Figures from Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice
17. Supplementary Table Legends from Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice
18. Data from Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers
19. Supplementary Fig S4 from Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers
20. Supplementary Methods from Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers
21. Supplementary Digs. S7 and S8 from Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers
22. Supplementary Figure 1 from Human Endogenous Retrovirus K Triggers an Antigen-Specific Immune Response in Breast Cancer Patients
23. Data from Human Endogenous Retrovirus K Triggers an Antigen-Specific Immune Response in Breast Cancer Patients
24. Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer
25. Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells
26. Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer
27. Sublingual injection of microparticles containing glycolipid ligands for NKT cells and subunit vaccines induces antibody responses in oral cavity
28. Unique potential of 4-1BB agonist antibody to promote durable regression of HPV⁺ tumors when combined with an E6/E7 peptide vaccine
29. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein
30. Cancer-associated Lactobacillus iners are genetically distinct and associated with chemoradiation resistance in cervical cancer
31. Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice
32. Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers
33. TSLP Production by Epithelial Cells Exposed to Immunodeficiency Virus Triggers DC-Mediated Mucosal Infection of CD4⁺ T Cells
34. Tumor-Resident Lactobacillus iners Confers Chemoradiation Resistance in Cervical Cancer Patients Through Acquired Metabolic Functions
35. TIGIT as a therapeutic target of HPV-positive head and neck squamous cell carcinomas
36. Procedures for Mucosal Immunization and Analyses of Cellular Immune Response to Candidate HIV Vaccines in Murine and Nonhuman Primate Models
37. Antiviral Effects of Oleandrin
38. Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates (Adv. Therap. 3/2021)
39. Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules
40. Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates
41. Effect of Antibiotics on Gut and Vaginal Microbiomes Associated with Cervical Cancer Development in Mice
42. Synthetic peptide-based reagents for blocking the entry and inactivation of HIV
43. Synthetic peptide-based HIV vaccine induces protective immunity in SHIV-rhesus model
44. Impairment of antigen-specific cellular immune responses under simulated microgravity conditions
45. Evaluation of cellular immune responses in rhesus monkeys subjected to adenovirus-mediated gene transfer into the cervix
46. Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant
47. Prophylactic and Therapeutic Inhibition of In Vitro SARS-CoV-2 Replication by Oleandrin
48. Intranasal Therapeutic Peptide Vaccine Promotes Efficient Induction and Trafficking of Cytotoxic T Cell Response for the Clearance of HPV Vaginal Tumors
49. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation
50. Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.